Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lue Katrine Drasbæk Philipsen"'
Autor:
Jane S. Lucas, Florian Gahleitner, Adelina Amorim, Mieke Boon, Philippa Brown, Carolina Constant, Simon Cook, Suzanne Crowley, Damien M.S. Destouches, Ernst Eber, Huda Mussaffi, Eric Haarman, Amanda Harris, Cordula Koerner-Rettberg, Claudia E. Kuehni, Philipp Latzin, Michael R. Loebinger, Natalie Lorent, Bernard Maitre, Antonio Moreno-Galdó, Kim G. Nielsen, Uğur Özçelik, Lue Katrine Drasbæk Philipsen, Petr Pohunek, Eva Polverino, Jessica Rademacher, Phil Robinson, Deborah Snijders, Panayiotis Yiallouros, Siobhán B. Carr
Publikováno v:
ERJ Open Research, Vol 5, Iss 1 (2019)
Pulmonary exacerbations are a cause of significant morbidity in patients with primary ciliary dyskinesia (PCD) and are frequently used as an outcome measure in clinical research into chronic lung diseases. So far, there has been no consensus on the d
Externí odkaz:
https://doaj.org/article/a4f6d3d43f0f40eca4b2c4e686ae25be
Autor:
Christian Voldby, Lue Katrine Drasbæk Philipsen, Kim G. Nielsen, Marianne Skov, Tacjana Pressler, Kent Green, Rikke Mulvad Sandvik, Frederik Buchvald
Publikováno v:
Journal of Cystic Fibrosis. 20:949-956
Background The lung clearance index (LCI) is increasingly used as an outcome in clinical trials of patients with mild cystic fibrosis (CF) lung disease. Yet, understanding the impact of standard CF respiratory therapy on LCI is needed. We assessed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2263612f02ae162785cd84f17f961084
https://doi.org/10.1016/j.jcf.2021.02.004
https://doi.org/10.1016/j.jcf.2021.02.004
Autor:
Rikke Møller, Bibi Uhre Nielsen, Daniel Faurholt‐Jepsen, Terese Lea Katzenstein, Marianne Skov, Lue Katrine Drasbæk Philipsen, Tacjana Pressler, Helle Krogh Johansen, Tavs Qvist
Publikováno v:
Møller, R, Nielsen, B U, Faurholt-Jepsen, D, Katzenstein, T L, Skov, M, Philipsen, L K D, Pressler, T, Johansen, H K & Qvist, T 2022, ' Use of inhaled antibiotics among Danish patients with cystic fibrosis ', Pediatric Pulmonology, vol. 57, no. 7, pp. 1726-1734 . https://doi.org/10.1002/ppul.25942
Background: Inhaled antibiotics are an important part of cystic fibrosis (CF) airway disease management and should be individualized to fit the microorganism and match patient needs. To investigate the implementation of personalized treatment, this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296dd99e4b01b1310059d56c699adb42
https://pubmed.ncbi.nlm.nih.gov/35478387
https://pubmed.ncbi.nlm.nih.gov/35478387
Autor:
Inger Hee Mathiesen, Linnea Chika Kristensen Ejiofor, Hanne Vebert Olesen, Lue Katrine Drasbæk Philipsen, Søren Jensen-Fangel, Camilla Lundgren Pedersen, Marianne Skov, Tacjana Pressler
Publikováno v:
Ejiofor, L C K, Mathiesen, I H M, Jensen-Fangel, S, Olesen, H V, Skov, M, Philipsen, L K D, Pedersen, C L & Pressler, T 2020, ' Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment ', Pediatric Pulmonology, vol. 55, no. 12, pp. 3364-3370 . https://doi.org/10.1002/ppul.25059
Background: Several studies have assessed safety and efficacy outcomes for lumacaftor/ivacaftor therapy. We report on lumacaftor/ivacaftor's impact on lung function, physical performance, and health-related quality of life (HRQOL) in a subpopulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87f4ee6719adc4f6c7d6b2d1857ab194
https://doi.org/10.1002/ppul.25059
https://doi.org/10.1002/ppul.25059
Autor:
Ulla Kildall Rysgaard, Camilla Lundgren Pedersen, Janne Hastrup Jensen, Lotte Sørensen, Lue Katrine Drasbæk Philipsen, Christian Leo-Hansen, Hanne Vebert Olesen
Publikováno v:
Rysgaard, U K, Pedersen, C L, Jensen, J H, Sørensen, L, Philipsen, L K D, Leo-Hansen, C & Olesen, H V 2022, ' Change in exercise capacity measured by Cardio-pulmonary Exercise Testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor/Ivacaftor and Tezacaftor/Ivacaftor ', Journal of Cystic Fibrosis, vol. 21, no. 5, pp. 844-849 . https://doi.org/10.1016/j.jcf.2022.05.009
BACKGROUND: Since 2015, when the first cystic fibrosis transmembrane conductance regulator (CFTR) modulators were approved for people with cystic fibrosis (CF) homozygous for F508del-CFTR, studies have shown improved lung function after initiation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecd873e7f915c4480c85ddb53562d9f
https://pubmed.ncbi.nlm.nih.gov/35667973
https://pubmed.ncbi.nlm.nih.gov/35667973
Autor:
Panayiotis K. Yiallouros, Carolina Constant, Amanda Harris, Simon Cook, Mieke Boon, Suzanne Crowley, Jane S. Lucas, Kim G. Nielsen, Cordula Koerner-Rettberg, Philippa Brown, Antonio Moreno-Galdó, Siobhán B. Carr, Huda Mussaffi, Philipp Latzin, Eric G. Haarman, Claudia E. Kuehni, Michael R. Loebinger, Natalie Lorent, Florian Gahleitner, Deborah Snijders, Adelina Amorim, Eva Polverino, Jessica Rademacher, Uğur Özçelik, Lue Katrine Drasbæk Philipsen, Bernard Maitre, Petr Pohunek, Phil Robinson, Damien M.S. Destouches, Ernst Eber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c68c0854600d1cbb72067b5452cb08c
https://doi.org/10.32388/729776
https://doi.org/10.32388/729776
Autor:
Kim G. Nielsen, Thomas Kongstad, Frederik Buchvald, Kent Green, Tanja Pressler, Per E. Gustafsson, Marianne Skov, Christian Voldby, Lue Katrine Drasbæk Philipsen
Publikováno v:
Journal of Cystic Fibrosis. 13
WS14.1 Day-time variability and short term effect of chest physiotherapy on multiple breath nitrogen washout in children with cystic fibrosis C. Voldby1, K. Green1, T. Kongstad1, L. Philipsen1, F.F. Buchvald1, M. Skov1, T. Pressler1, P. Gustafsson2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00ba8f913cdb06d036fc3b94e9c0d6f